Trastuzumab
A recombinant IgG1 kappa, humanized monoclonal antibody that selectively binds with high affinity in a cell-based assay (Kd = 5 nM) to the extracellular domain of the human epidermal growth factor receptor protein. Produced in CHO cell culture.
| Trivial name | IGHG1 |
| Catalog Number | TP-083CL |
| Alternative Name(s) | Trastuzumab |
| Research Area | Cancer |
| Molecular Formula | C6470H10012N1726O2013S42 |
| CAS# | 180288-69-1 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Trastuzumab-22421.htm |
| Additional Information | For treatment of early stage HER2-positive breast cancer, or metastatic breast cancer that substantially overexpress HER2. |